A phase 3 randomized placebo-controlled trial to assess the efficacy and safety of ipragliflozin as an add-on therapy to metformin in Russian patients with inadequately controlled type 2 diabetes mellitus



Shestakova, Marina V, Wilding, John PH ORCID: 0000-0003-2839-8404, Wilpshaar, Wim, Tretter, Reiner, Orlova, Valeria L and Verbovoy, Andrey F
(2018) A phase 3 randomized placebo-controlled trial to assess the efficacy and safety of ipragliflozin as an add-on therapy to metformin in Russian patients with inadequately controlled type 2 diabetes mellitus. DIABETES RESEARCH AND CLINICAL PRACTICE, 146. 240 - 250.

[img] Text
Shestakova Ipragliflozin accepted versionpdf.pdf - Accepted Version

Download (1MB)
Item Type: Article
Uncontrolled Keywords: Diabetes mellitus, type 2, Ipragliflozin, Metformin, Randomized controlled trial, Sodium-glucose co-transporter-2 (SGLT2) inhibitor
Depositing User: Symplectic Admin
Date Deposited: 08 Nov 2018 15:03
Last Modified: 19 Aug 2022 12:13
DOI: 10.1016/j.diabres.2018.10.018
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3028584